Congestive heart failure occurs when the heart is unable to pump enough blood to meet the body's needs. The document discusses the pathophysiology and various treatment approaches for congestive heart failure. Pharmacological treatments discussed include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists. Newer potential treatments discussed are coenzyme Q10 and BET protein inhibitors. Non-pharmacological treatments discussed are stem cell therapy, gene therapy, cardiac devices like pacemakers, defibrillators and resynchronization therapy, as well as continuous positive airway pressure. The document concludes that while heart failure was once seen as incurable, new gene and stem cell therapies now offer promise for reversing syst
Coagulant & AntiCoagulant Haemostasis (arrest of blood loss) and blood coagulation involve complex interaction between the injury vessel wall, platelets and coagulation factors
Coagulant & AntiCoagulant Haemostasis (arrest of blood loss) and blood coagulation involve complex interaction between the injury vessel wall, platelets and coagulation factors
Individualized Webcam facilitated and e-Classroom USMLE Step 1 Tutorials with Dr. Cray. Starting at $50.00/hr., depending on pre-assessment. 1 BMS Unit is 4 hr. General Principles and some Organ System require multiple units to complete in preparation for the USMLE Step 1 A HIGH YIELD FOCUS IN Biochemistry / Cell Biology, Microbiology / Immunology and the 4 P’s-Phiso, Pathophys, Path and Pharm. Webcam Facilitated USMLE Step 2 Clinical Knowledge and Clinical Skills diadactic tutorials /1 Unit is 4 hours, individualized one-on-one and group sessions, Including all Internal Medicine sub-sub-specitialities. For questions or more information.. drcray@imhotepvirtualmedsch.com
Pathogenesis and Medicolegal aspect of shock Soreingam Ragui
shock is one of the main cause of death very common encountered in day to day practice,in this presentation we look at how it happen,what are the causes and how we diagnose it in brief and its forensic importance
shock is a Life threatening clinical syndrome of cardio-vascular collapse characterized by Hypotension and Hypoperfusion. If uncompensated, these mechanisms may lead to impaired cellular metabolism and death.
Individualized Webcam facilitated and e-Classroom USMLE Step 1 Tutorials with Dr. Cray. Starting at $50.00/hr., depending on pre-assessment. 1 BMS Unit is 4 hr. General Principles and some Organ System require multiple units to complete in preparation for the USMLE Step 1 A HIGH YIELD FOCUS IN Biochemistry / Cell Biology, Microbiology / Immunology and the 4 P’s-Phiso, Pathophys, Path and Pharm. Webcam Facilitated USMLE Step 2 Clinical Knowledge and Clinical Skills diadactic tutorials /1 Unit is 4 hours, individualized one-on-one and group sessions, Including all Internal Medicine sub-sub-specitialities. For questions or more information.. drcray@imhotepvirtualmedsch.com
Pathogenesis and Medicolegal aspect of shock Soreingam Ragui
shock is one of the main cause of death very common encountered in day to day practice,in this presentation we look at how it happen,what are the causes and how we diagnose it in brief and its forensic importance
shock is a Life threatening clinical syndrome of cardio-vascular collapse characterized by Hypotension and Hypoperfusion. If uncompensated, these mechanisms may lead to impaired cellular metabolism and death.
This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy students and medication and the kids are not as good as you can do with a bit of snow here and growing physically and mentally drained from and working wonders awaiting results from work tomorrow morning to make sure you can get the money back to you can tell me what you want me when you can get it for pharmacy students and medication and a HS for pharmacy students and medication for pharmacy students and medication for pharmacy students This presentation is very important for pharmacy stude
Cardiogenic shock is a condition of diminished cardiac output that severely impairs cardiac perfusion. In this condition in which the heart suddenly can't pump enough blood to meet the body's needs.
The file gives the information of Cardiac Failure. Etiology of cardiac failure, types, stages of cardiac failure. It also covers the multisystem effects of cardiac failure, classification of drugs acting on cardiac failure.
Similar to Congestive heart failure a path from conventional to aadvance therapy (20)
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. CONGESTIVE HEART FAILURE:
A PATH FROM
CONVENTIONAL TO ADVANCE THERAPY
PRESENTED BY
MOMIN ALTAMASH
M PHARM 1 ST YEAR
(PHARMACOLOGY)
ROLL NO. 22
GUIDED BY
http://www.freewebs.com
MR VINOD GUPTA
2
3. Table of Contents :
1.
INTRODUCTION
2.
PATHOPHYSIOLOGY
3.
PHARMACOLOGICAL TREATMENT OF CONGESTIVE HEART FAILURE
4.
NEWER DRUGS UNDER RESEARCH
5.
ADVANCES IN THE TREATMENT
6.
NON PHARMACOLOGICAL TREATMENT
7.
CONCLUSION
8.
REFRENCES
3
4. 1 ) Introduction :
CONGESTIVE HEART FAILURE
Factors that may produce congestive heart failure
Obstruction
Inflammation
Malnutrition
Insufficiency
Oxygen lack
Anaemia
Raised pressure
Toxins
Hyperthyroidism
4
6. 2) Pathophysiology of Congestive Heart Failure :
• Congestive heart failure is the pathophysiologic state in which –
• the heart is unable to pump blood at a rate commensurate with the requirements
of metabolizing tissues, or can do so only from an elevated filling pressure
(Braunwald and Bristow, 2000).
• Heart failure is a complex of symptoms –
• That is fatigue, shortness of breath, and congestion that are related to the
inadequate perfusion of tissue during exertion and often to the retention of fluid.
Its primary cause is an impairment of the heart's ability to fill or empty the left
ventricle properly (Cohn, 1996).
6
8. Preload is a passive stretching force exerted on the
ventricular muscle at the end of diastole. Preload is caused
by the volume of blood in the ventricle at the end of
diastole.
Afterload is the force resisting the contraction of the
cardiac muscle fibers. Afterload can also be considered
as the blood pressure exerted on the Atrial Valve during
diastole
John Burton,
MD- Albany
Medical CenterAlbany, New
York
Contractility refers to the ability of cardiac muscle fibers to
shorten when stimulated (strength
8
10. • Compensatory mechanisms may restore CO to near-normal.
• But, if excessive the compensatory mechanisms can worsen heart failure because . . .
• Vasoconstriction: ↑’s the resistance against which heart has to pump (i.e., ↑’s
afterload), and may therefore ↓ CO
• Na and water retention: ↑’s fluid volume, which ↑’s preload. If too much “stretch” ↓
strength of contraction and ↓’s CO
• Excessive tachycardia → ↓’d diastolic filling time → ↓’d ventricular filling → ↓’d SV
and CO
10
11. 3) PHARMACOLOGICAL TREATMENT
CONGESTIVE OF HEART FAILURE :
Drug Classes
Used To Treat
CHF :
Cardiac
Glycosides
β blockers
(ACE Inhibitors)
and AT1 Receptor
Antagonists
Diuretics
Vasodilators
Aldosterone
Antagonists
11
12. 3.1] The Cardiac Glycosides (Cardenolides):
•
Drug Members :
i.
Digitoxin (Crystodigin)
ii. Digoxin (Lanoxin)
iii. Deslanoside (Cedilanid-D)
•
Mechanisms of Action :
http://cvpharmacology.com
12
13. • The net effect of the glycosides on the heart is as follows :
a. heart rate is slowed
b. contraction is greater due to increased filling volumes
c. ejection fraction is improved
d. increased ejection velocity
• Adverse Side Effects Of The Glycosides :
Fatigue, delirium, anorexia, headaches, hallucinations.
13
14. 3.2] Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors) and
AT1 Receptor Antagonists:
•
Drug Members:
• Captopril (Capoten)
• Enalapril (Vasotec)
• Lisinopril (Prinivil)
Mechanism:
•
AT1 receptor antagonists should
at present be viewed as the preferred
alternative when ACE inhibitors cannot be tolerated
http://www.uspharmacist.com
•
Adverse Side Effects : GI distress, dizziness, skin rashes, hypotension
14
15. 3.3) BETA-BLOCKERS:
http://www.cardiachealth.org
Beta-blockers may work by slowing the heart rate, which allows the left
ventricle (the main pumping chamber of the heart) to fill more completely.
some of these medicines may also help open or widen blood vessels in the
body. this makes them especially useful in some people with certain forms of
heart failure who may also have high blood pressure
15
19. 4) NEWER DRUGS UNDER RESEARCH
•
4.1) Coenzyme Q10 :
•
occurs naturally in the body and is essential to survival.
• Acts as an electron carrier in the mitochondria,
http://www.netrition.com
• CoQ10 levels are decreased in the heart muscle of patients with heart failure,
• Double blind controlled trials have shown that CoQ10 improves symptoms,
functional capacity and quality of life in patients with heart failure with no side
effects
• "Other heart failure medications block rather than enhance cellular processes and
may have side effects.
• Supplementation with CoQ10, which is a natural and safe
19
20. • It corrects a deficiency in the body and blocks the vicious metabolic cycle
in chronic heart failure called the energy starved heart.“
•
sources-Q10 is present in food, including red meat, plants and fish, but
levels are insufficient to impact on heart failure.
• CoQ10 is also sold over the counter as a food supplement.
•
Coenzyme Q10 decreases all cause mortality by half.
•
It is the first drug to improve heart failure mortality in over a decade and
can be added to standard treatment .
http://www.vitacost.com
20
21. •4.2) Bromodomain and extraterminal domain (BET) protein inhibitors :
Current therapies are not adequately effective at improving health and preventing
deaths.
Bromodomain and extraterminal domain (BET) proteins activates genes that
contribute to heart failure.
Heart failure may be triggered by the activation of a large set of genes that cause
the walls of the heart to thicken and develop scar tissue, impairing the organ's
ability to pump blood normally.
21
22. BET proteins can have a huge impact on gene activity because they belong to a
class of molecules called epigenetic readers, which recognize special marks on
DNAprotein complexes and attract gene-activating proteins to those spots.
BET inhibitor called JQ1 shows promise in treating heart failure. JQ1 protect
against heart-wall thickening, the formation of scar tissue, and pump failure
22
24. 5.1) Stem cell therapy.
• Stem cells - These are undifferentiated cells that can differentiate into
specialized cell types. stem cells come from 3 main sources:
i.
Embryonic stem cells,
ii. Adult tissue (adult stem cells).
iii. Endometrial stem cells.
24
25. CLASSIFICATION
1
Adult stem cells
2
Embryionic stem cells
3
Endometrial stem cells
Exist throughout the body after
embryonic development. found in tissues
such as the brain, bone marrow, blood,
blood vessels, skeletal muscles, skin, and
the liver.
Derived from a four- or five-day-old human
embryo that is in the blastocyst phase of
development. in IVF (in vitro fertilization)
clinics there are extra embryos. only one is
implanted into a woman from several eggs
fertilized in a test tube.
It involves extraction of a small amount of
menstrual blood from young healthy donors
that is called as endometrial stem cells.
25
27. • Possible mechanisms of recovery include:
• Generation of heart muscle cells,
• Stimulation of growth of new blood vessels to repopulate damaged heart
tissue,
• Secretion of growth factors,
• Assistance via some other mechanism,
27
28. • PROCEDURE OF STEM CELL THERAPY
1.
COLLECTION
2. PROCESSING AND
CRYOPRESRVATION
3. INFUSION
4. ENGRAFMENT
AND RECOVERY
28
29. 5.2) GENE THERAPY :
• Gene therapy is the use of DNA as a pharmaceutical agent to
treat disease. Gene therapy is a technique that uses genes to treat
or prevent disease.
• Researchers are testing several approaches to gene therapy,
including:
• Replacing a mutated gene that causes disease with a healthy
copy of the gene.
• Inactivating, or “knocking out,” a mutated gene that is
functioning improperly.
• Introducing a new gene into the body to help fight a disease .
29
31. • SARCOENDOPLASMIC RETICULUM (SER):
• Sarcoplasmic reticulum activated by Ca2+ leads to contraction.
• In heart failure, decrease expression of Ca2+ causes impairment of SER.
• widely used viruses for gene delivery to heart are recombinant AAVs (adeno
associated virus).They are relatively sective for cardiac myocites
• There is high diastolic and low systolic Ca2+ levels when SER is impaired.
Studies has shown that by increasing SER Ca2+ expression by viral transduction
of SER Ca2+ transgene, heart failure can be treated .
31
32. • OTHER TARGETS
a) PHOSPHOLAMBAN:
•
It is a protein that regulates the calcium pump in cardiac muscle.
•
This protein is a potent inhibitor of sarcoplasmic reticulum ca 2+ ATPase in
unphosphorylated state, but inhibition is relieved upon phosphorylation.
•
Inhibitory phospholamban, antisense and psuedophosphorylated state mutant is
used in heart failure by viral delivery.
32
33. b) ADENYLYL
CYCLASE 6
protein kinase a
phosphorylates
phospholamban
and SERCA2A
activity is
enhanced.
FIG: ROLE OF ADENYLYL CYCLASE (AC6) IN HEART
CONTRACTION
http:/www.sciencedirect.com
Symptoms of
heart failure is
alleviated by viral
delivery of AC6
transgene as result
of SERCA2a
function.
33
34. c) PROTEIN PHOSPHATASE 1
•
It is involved in the regulation of a variety of cellular processes,.
• Increased PP1 activity has been observed in the end stage of heart
failure
• SR ca2+ upake is suppressed by the (ppi) because it
dephosphorylates the phospholamban.
•
Pp1 is reduced using (sh)RNA and has showed improved cardiac
function and reduced interstitial fibrosis in mouse model of heart
failure.
34
35. d) SMALL UBIQUITINE LIKE MODIFIER (SUMO 1 ) :
• SUMO 1 is a key component in cardiac function .
• The interaction between SUMO 1 and SERCA2A is crucial for
regulating calcium levels inside cardiac myocytes.
• Reduction in SUMO 1 protein reduces SERCa2+, and thus
efficient calcium handling in patients with failing hearts .
• Introduction of SUMO 1 through gene therapy is associated with
improved activity of SERCA2A, which resulted in improved
cardiac function through an augmentation of cardiac contractility.
35
37. • GENE DELIVERY METHODS ;
A) Transvascular
intracoronary antegrade and retrograde delivery :
B) Direct intramyocardial delivery :
http://www.sciencedirect.com
37
38. 6) Device therapy :
• Damage to the heart muscle can cause changes in the
electrical system of the heart.
• There are three different types of devices that can be
used in the treatment of heart failure to correct an
abnormal heartbeat.
38
39. I. Pacemakers :
• The traditional pacemaker has two parts: lead wires
and a pulse generator, which houses a battery and a
tiny computer.
• The lead wires sense the heart's electrical activity, and
when the computer determines that the heart rhythm is
off, it responds by sending electrical impulses to the
heart muscle to correct its rate.
• Pacemakers are usually used to treat heart rhythms that
are too slow. But they can also be used to treat fast
rhythms or to increase the heart rate in response to
changes in the patient's activity level
39
41. 3) Internal cardioverter defibrillator (ICD):
ICD senses electrical activity and sends a shock to the heart if it
detects a dangerous heart rhythm implantable cardiac
defibrillators reduce the risk of death from sudden cardiac arrest
by 23 percent in patients with heart failure
41
42. • Continuous positive airway pressure(CPAP):
• To improve the prognosis of CHF, additional novel approaches to its
therapy are required. One promising approach is the use of
continuous positive airway pressure (CPAP ).
• When applied via a nasal mask, CPAP provides a noninvasive
mechanical assist to the failing heart by increasing intrathoracic
pressure and augmenting stroke volume and cardiac output,CPAP
improves the mechanical efficiency of the failing heart possibly
through reverse ventricular remodeling.
42
43. 7)
Conclusion
Heart failure is a major health issue with a high rate of
morbidity and mortality
Thus, there is a substantial need for new strategies to
prevent the progression of heart failure.
Until now, heart
failure was seen as an incurable disease.
However, gene
therapy approach have offered the promise of an effective
therapy for reversing systolic heart failure
Great advances in understanding the pathobiology
of HF and their application to further improvements of patient care are withun reach
43
44. Time will tell whether a single target
approach is sufficient to restore heart function and prevent
deterioration or whether multiple gene targets are needed
along with stem cell therapy to eventually replace the
injured myocardium.
Using a viral-delivery gene therapy
approach to treat heart failure by enhancing contractility is
not yet a reality, but substantial progress in that direction
has been made in the last few years.
Great advances in understanding the pathobiology
of HF and their application to further improvements of patient care are
within reach
44
45. •
Refrences
•
1. Beltrami, A.P., Urbanek, K., Kajstura, J., Yan, S.M., Finato, N., Bussani, R., Nadal-Ginard, B., Silvestri, F.,
Leri, A.,
Beltrami, C.A., and Anversa, P. (2001). Evidence that human cardiac myocytes divide after myocardial infarction.
N. Engl. J. Med. 344, 1750–1757.
•
2 . Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., and Benvenisty, N.
(2000).
Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers.
Mol. Med.
6, 88–95.
•
3. Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W., Entman, M.L., Michael, L.H.,
Hirschi, K.K.,
and Goodell, M.A. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.
J. Clin.
Invest. 107, 1–8.
•
4. Kehat, I., Kenyagin-Karsenti, D., Druckmann, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O.,
Itskovitz-Eldor,
J., and Gepstein, L. (2001). Human embryonic stem cells can differentiate into myocytes portraying
cardiomyocytic
structural and functional properties. J. Clin. Invest. (in press)
•
5. Kessler, P.D. and Byrne, B.J. (1999). Myoblast cell grafting into heart muscle: cellular biology and potential
applications.
Annu. Rev. Physiol. 61, 219–242.
45